REVELATION BIOSCIENCES, INC. Increase (Decrease) in Prepaid Expense and Other Assets
REVELATION BIOSCIENCES, INC. (REVB) reported Increase (Decrease) in Prepaid Expense and Other Assets of $148.40 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $109.10K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $39.30K, a 74.90% decline year-over-year.
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$12.64K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$62.12K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $44.60K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$17.99K, a 255.65% decline from fiscal 2023.
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $11.56K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$569.04K, a 211.72% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $109.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $148.40K 10-Q · filed 2026-08-06 | $135.76K derived: sum of 3 quarters · filed 2026-08-06 | $73.65K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $39.30K 10-Q · filed 2026-05-07 | $26.66K derived: sum of 2 quarters · filed 2026-05-07 | -$35.45K derived: sum of 3 quarters · filed 2026-05-07 | -$72.68K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$12.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$74.75K derived: sum of 2 quarters · filed 2026-02-26 | -$111.97K derived: sum of 3 quarters · filed 2026-08-06 | $44.60K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$62.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$99.34K derived: sum of 2 quarters · filed 2026-08-06 | $57.23K 10-Q · filed 2025-11-06 | $6.09K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$37.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $119.35K 10-Q · filed 2026-08-06 | $68.20K derived: sum of 3 quarters · filed 2026-08-06 | $60.31K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $156.57K 10-Q · filed 2026-05-07 | $105.42K derived: sum of 2 quarters · filed 2026-05-07 | $97.53K derived: sum of 3 quarters · filed 2026-05-07 | $151.39K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$51.15K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$59.04K derived: sum of 2 quarters · filed 2026-02-26 | -$5.18K derived: sum of 3 quarters · filed 2026-02-26 | -$17.99K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$7.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $45.97K derived: sum of 2 quarters · filed 2025-11-06 | $33.16K 10-Q · filed 2025-11-06 | -$34.79K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $53.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $41.05K 10-Q · filed 2025-08-08 | -$26.89K derived: sum of 3 quarters · filed 2025-08-08 | -$124.27K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$12.81K 10-Q · filed 2025-05-08 | -$80.76K derived: sum of 2 quarters · filed 2025-05-08 | -$178.14K derived: sum of 3 quarters · filed 2025-05-08 | -$260.51K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$67.95K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$165.32K derived: sum of 2 quarters · filed 2025-03-06 | -$247.70K derived: sum of 3 quarters · filed 2025-03-06 | $11.56K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$97.38K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-08 | -$179.75K derived: sum of 2 quarters · filed 2024-11-08 | $79.50K 10-Q · filed 2024-11-08 | -$156.99K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$82.38K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-09-23 | $176.88K 10-Q/A · filed 2024-09-23 | -$59.62K derived: sum of 3 quarters · filed 2024-09-23 | -$325.47K derived: sum of 4 quarters · filed 2024-09-23 |
| 2023-03-31 | $259.25K 10-Q/A · filed 2024-09-23 | $22.76K derived: sum of 2 quarters · filed 2024-09-23 | -$243.09K derived: sum of 3 quarters · filed 2024-09-23 | -$352.39K derived: sum of 4 quarters · filed 2024-09-23 |
| 2022-12-31 | -$236.50K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-23 | -$502.35K derived: sum of 2 quarters · filed 2024-09-23 | -$611.65K derived: sum of 3 quarters · filed 2024-09-23 | -$569.04K 10-K/A · filed 2024-09-23 |
| 2022-09-30 | -$265.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$375.15K derived: sum of 2 quarters · filed 2023-11-09 | -$332.55K 10-Q · filed 2023-11-09 | -$1.26M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$109.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$66.69K 10-Q · filed 2023-08-11 | -$994.00K derived: sum of 3 quarters · filed 2023-08-11 | -$1.11M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $42.60K 10-Q · filed 2023-05-22 | -$884.70K derived: sum of 2 quarters · filed 2023-05-22 | -$1.00M derived: sum of 3 quarters · filed 2023-05-22 | $553.09K derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | -$927.30K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.05M derived: sum of 2 quarters · filed 2023-03-30 | $510.49K derived: sum of 3 quarters · filed 2023-03-30 | $509.34K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$119.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.44M derived: sum of 2 quarters · filed 2022-11-10 | $1.44M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.56M 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | -$1.14K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |